Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis

Area of Science:

• Cardiovascular Medicine
• Hepatology
• Clinical Pathophysiology

Background:

• Patients with cirrhosis and portal hypertension present with distinct hemodynamic alterations.
• These include hyperdynamic circulation, altered blood volume distribution, and neurohumoral imbalance.

Purpose of the Study:

• To elucidate the pathophysiological mechanisms underlying cardiovascular dysfunction in cirrhosis.
• To highlight the role of hemodynamic and neurohumoral abnormalities in disease progression and therapeutic considerations.

Main Methods:

• Review of existing literature on hemodynamic and neurohumoral changes in cirrhosis.
• Analysis of pathophysiological mechanisms contributing to cirrhotic cardiomyopathy.
• Examination of the interplay between cardiovascular dysfunction and organ function.

Main Results:

• Cirrhosis leads to increased plasma and noncentral blood volumes, with significant splanchnic vasodilation.
• Cardiac dysfunction, termed cirrhotic cardiomyopathy, involves impaired systolic and diastolic functions.
• Mechanisms include altered beta-adrenergic signaling, impaired excitation-contraction coupling, and ion channel dysfunction.

Conclusions:

• Hemodynamic and neurohumoral dysregulation in cirrhosis contribute to a generalized cardiovascular dysfunction.
• This dysfunction influences disease progression, leading to reduced organ function and fluid retention.
• Understanding these mechanisms is crucial for developing effective therapeutic interventions.